Spyros Papapetropoulos

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 108 citations

Medicine, Neurology, Pharmacology +10

Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease

Marta Garcia‐Miralles, Xin Hong, Liang Tan et al. · Scientific Reports · 2016 · 67 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action

Irl B. Hirsch, Joe Martinez, E. Ray Dorsey et al. · Clinical Therapeutics · 2017 · 58 citations · Full text

Health Professions, Clinical Pharmacy, Health Informatics +15

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

Shani Cohen, Zeev Waks, Jordan J. Elm et al. · BMC Medical Informatics and Decision Making · 2018 · 45 citations · Full text

Medicine, Health Informatics, Neurology +15

Application of Machine Learning in a Parkinson's Disease Digital Biomarker Dataset Using Neural Network Construction (NNC) Methodology Discriminates Patient Motor Status

Ioannis G. Tsoulos, Georgia Mitsi, Athanassios Stavrakoudis et al. · Frontiers in ICT · 2019 · 44 citations · Full text

Computing, Health Informatics, Neurology +17